Good morning. Remember, if you think nonclinical is expensive — try skipping it. Go break some eggs.
Read it here →
📥 Subscriber download: The Adverse Finding Checklist
Because you're a subscriber to The Nonclinical, here's the checklist version of everything in this issue — formatted as a one-page reference you can use every time a finding comes back from your CRO.
Five questions. Three columns per question: what to look for, what good documentation looks like, and the red flag to watch for.
Myth
Reality
📍 This week's newsletter is one lesson in a 14-module course.
If this framework is the kind of thinking you want to build into how you approach nonclinical development — not just for adverse findings, but for study design, species selection, dose selection, regulatory strategy, and IND submission — The Complete Guide to Nonclinical Development is now live.
60+ hours. 14 modules. Built by a board-certified toxicologist who has been in the room.
Three tiers and Course Justification Letters available so your company can pay for it.
Start when you're ready. Go at your own pace.
Enroll here 👉 https://www.nonclinical.academy/
